home / stock / silo / silo short
Short Information | Silo Pharma Inc. (NASDAQ:SILO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,419,275 |
Total Actual Volume | 12,380,439 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 70,964 |
Average Short Percentage | 19.72% |
Is there a SILO Short Squeeze or Breakout about to happen?
See the SILO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
12-12-2024 | $0.96 | $0.922 | $0.96 | $0.889 | 89,716 | 25,261 | 28.16% |
12-11-2024 | $0.94 | $0.9496 | $0.98 | $0.9211 | 74,093 | 12,959 | 17.49% |
12-10-2024 | $0.91 | $0.94 | $0.95 | $0.9031 | 21,253 | 5,005 | 23.55% |
12-09-2024 | $0.928 | $0.903 | $0.96 | $0.9 | 214,821 | 80,226 | 37.35% |
12-06-2024 | $0.92 | $0.924 | $0.95 | $0.9 | 161,357 | 26,695 | 16.54% |
12-05-2024 | $0.98 | $0.93 | $0.98 | $0.911 | 124,047 | 19,222 | 15.5% |
12-04-2024 | $1.02 | $0.969 | $1.02 | $0.9601 | 144,698 | 40,308 | 27.86% |
12-03-2024 | $0.95 | $1 | $1.05 | $0.95 | 132,551 | 13,040 | 9.84% |
12-02-2024 | $0.99 | $1.05 | $1.11 | $0.8599 | 812,973 | 113,487 | 13.96% |
11-29-2024 | $1.03 | $1 | $1.1 | $0.933 | 8,598,610 | 695,232 | 8.09% |
11-27-2024 | $0.93 | $0.9 | $0.943 | $0.8506 | 87,263 | 10,865 | 12.45% |
11-26-2024 | $0.8449 | $0.88 | $0.9 | $0.8449 | 83,912 | 11,122 | 13.25% |
11-25-2024 | $0.86 | $0.871 | $0.89 | $0.77 | 109,432 | 28,422 | 25.97% |
11-22-2024 | $0.91 | $0.86 | $0.9878 | $0.83 | 141,926 | 25,680 | 18.09% |
11-21-2024 | $0.93 | $0.91 | $0.95 | $0.91 | 101,938 | 12,732 | 12.49% |
11-20-2024 | $0.97 | $0.9451 | $1.01 | $0.9302 | 128,900 | 27,275 | 21.16% |
11-19-2024 | $1 | $0.9699 | $1.04 | $0.96 | 185,973 | 32,121 | 17.27% |
11-18-2024 | $1.08 | $0.99 | $1.1 | $0.98 | 830,166 | 143,846 | 17.33% |
11-15-2024 | $1.14 | $1.13 | $1.2116 | $1.1 | 221,630 | 60,450 | 27.28% |
11-14-2024 | $1.15 | $1.15 | $1.18 | $1.07 | 115,180 | 35,327 | 30.67% |
News, Short Squeeze, Breakout and More Instantly...
Silo Pharma (NASDAQ: SILO) has entered into a collaboration with Kymanox to develop a subcutaneous insertion device for SP-26, its ketamine-loaded implant designed to treat fibromyalgia and chronic pain. The partnership will begin with proof-of-concept design, followed by prototype and feasibili...
Prototype development and feasibility testing underway for optimized subcutaneous delivery SARASOTA, FL, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on dev...
Dual-action approach combining 5-HT4R Agonist (SPC-15) and NMDAR antagonist demonstrates enhanced efficacy in preclinical study for managing severe conditions The Company is currently developing SPC-15 as an intranasal treatment for PTSD SARASOTA, FL, Nov. 18, 2024 (GLOBE NEWSWIRE...